Objective: To describe the clinical, hematological and radiographic characteristics of children hospitalized for Mycoplasma pneumoniae pneumonia.
Introduction
Mycoplasma pneumoniae (MP) is a major etiologic agent behind community-acquired pneumonia. The factors include poor familiarity with clinical status, lack of quick and specific exams during the initial stage (often unavailable in most practices), and difficulty culturing said microorganisms in laboratories. 1 Identifying the etiologic agent is a key challenge for pneumonia. In everyday practice, clinicians usually resort to empirical treatment, since the agent is only identified in 40 to 60% of cases, 2,3 and can sometimes not be the sole case of the pneumonia. MP does not grow in the media usually employed for bacterial culture, and does not turn the media opaque when it does grow. Colonies formed in solid media cannot be seen under optical microscopes and, since they are Gramnegative, cannot be detected by sputum bacterioscopy either.
Therefore, diagnosis requires specific exams; currently, the most frequent are serological exams and the polymerase chain reaction (PCR), with sensitivity and specificity varying according to the kit used. 1 The objective of this study is to describe a clinical, hematological and radiographic profile of children hospitalized for MP pneumonia, comparing it to the profile of pneumonia caused by other etiologic agents.
Method
This cross-sectional, observational study recruited in Clinical, hematological and radiographic differences, as well as the score for both groups (MP pneumonia and pneumonia from other etiologic agents) were analyzed using the chi-square test, Fisher's exact test, Student's t test, and Mann-Whitney test. Significance, i.e., probability at which the null hypothesis is rejected, was set at 0.05 or 5% (a < 0.05).
The study was approved by the research ethics committee of the hospital (protocol number 34/04) and of Universidade
Federal de Minas Gerais (protocol ETIC 0421/06). Table 1 Table 1) . Table 2 compares the frequency of extrapulmonary manifestations in both groups with statistically significant differences (p < 0.01), especially in terms of cardiac
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alterations (p = 0.02).
Comparison between groups with MP pneumonia and pneumonia caused by other etiologic agents with score suggestive of bacterial condition
There was no statistically significant difference between the presence of children younger than 9 months old in the Regarding presence of anemia (defined as hemoglobin ≤ 11 g/dL), leukocytes ≥ 12,000 cells/mm 3 and neutrophils ≥ 8,000 cells/mm 3 , there was no statistically significant difference. However, the presence of immature neutrophils above 5% was highest in the group suggestive of bacterial pneumonia (p < 0.01) ( Table 3) .
Comparison of radiographic aspects shows that MP had higher frequency of poorly defined or diffuse and interstitial infiltrate; and the other group had greater lobar and lobular aspect at a statistically significant rate (p = 0.03). Pleural effusion was present in both groups, but the group with score suggestive of bacterial pneumonia had it at higher rates (p = 0.03) and also more apparent (p < 0.01) ( Table 3) .
The difference between the scores of the two groups was statistically significant (p < 0.01). The presence of leukocytes ≥ 12,000 cells/mm 3 and neutrophils ≥ 8,000 cells/mm 3 was larger in the group positive for MP (both with p < 0.01), as well as the presence of bands ≥ 5% (p = 0.02) ( Table 3) .
Comparison of radiographic aspects shows that the group with scores suggestive of viral pneumonia had more diffuse, interstitial and peribronchial infiltrate, located in multiple lobes, perihilar, poorly defined, and with absence of apparent pleural effusion (all p < 0.01) ( Table 3) .
The difference between the scores of the two groups was statistically significant (p < 0.01). The group with MP pneumonia had a score ranging from 0 to 15 points, with mean and standard deviation of 6.95±3.13 and a median of 7; the group with viral scores ranged from -2 to -3 points, with mean and standard deviation of 0.90±1.65 and a median of 1 (Table 3) .
Discussion
In terms of clinical variables, mean age was highest in the group suffering from MP pneumonia. Age is an important predictor of etiologic agent in pneumonia. 11, 12 13 found hospitalization rates of 67% for children younger than 4 years old, 5% for children 5 to 9 years old, and 9% for children 10 to 14 years old. The present study assessed only hospitalized children, which explains its large share of subjects younger than 5 years old.
In this study, female patients were more common in the MP positive group. This matches the work by HeiskanenKosma et al., 16 who describe higher rates of incidence for female (2.1 cases/1,000 children/year) rather than male (1.3 cases/1,000 children/year) patients.
In MP pneumonia, symptoms usually appear gradually and can persist for weeks or months. 17 Disease course was longest in the positive serology group (120 days), compared to the 45 days of the negative serology group. Dry cough was most frequent in the positive serology group. According to the literature, when the MP infection is located in the trachea, bronchi and bronchioles, the result is constant, uncontrollable, nonproductive coughing, awakening the patient in the middle of the night and preventing them from going back to sleep. 17 We should stress that the absence of this symptom does not rule out MP infection, and that absence of coughing was greater for the positive serology group (22.11%) than for negative cases (13.68%).
Fever above 39 °C suggests bacterial infection, while low intensity fever is usually associated with viral infections. 18 In this study, fever in MP pneumonia was lower than in bacterial infections and higher than in viral ones.
Increased bands immature neutrophil count in patients
without MP is caused by more acute statuses. In MP pneumonia, symptoms usually have a more insidious onset, a fact reflected in blood tests. 17 Leukocytes ≥ 12,000 cells/ mm 3 are not statistically different among groups, but the variable is not part of the score. 8 The however, they are closer to bacterial pneumonia scores.
In the literature, viral infection is also associated to the interstitial peribronchial and perihilar infiltrate aspect, and is rarely concurrent with pleural effusion. Alveolar disease, consolidation, presence of aerial bronchogram, and pleural effusion are all characteristics of bacterial pneumonia. 18, 20, 23 According to the literature, the radiographic aspect of MP lies between the viral and bacterial aspects. 23 In the present study, radiographic comparison showed that infiltrate was more lobar, lobular and well defined in pneumonia with scores suggestive of bacteria, more poorly defined in MP pneumonia, and more diffuse, interstitial and peribronchial in cases of likely viral etiology.
Pleural effusion was apparent in bacterial pneumonia, almost absent in nonbacterial ones, and present, though often minimal, in MP pneumonia. The literature includes a study which evaluated 81 children with pleural effusion, which found Streptococcus pneumoniae in 20% of cases, followed by MP in 18%. 24 A potential limitation of this study is its population, which consists of inpatients at a tertiary hospital, often referred to it by other practices. The score used in the study was developed based exclusively on a etiologic survey of viruses and typical bacteria, which did not include MP.
Results suggest some clinical, hematological and radiographic characteristics present in patients may contribute to the presumptive diagnosis of MP pneumonia and aid the process of differentiating it from cases cause by other etiologic agents.
In most cases, MP pneumonia scored between bacterial and viral pneumonia, though closer to the first. Therefore, if resources to confirm the diagnosis of MP pneumonia are unavailable, a score suggestive of bacterial etiology and lack of response to the antibiotics most commonly employed in the initial treatment for community-acquired pneumonia raise the possibility of MP pneumonia. In these cases, physicians should consider switching current antibiotics to macrolides.
